drugset
Drugs / MN rsgp120/HIV-1
last change Apr 2005 re-read 2 minutes ago

MN rsgp120/HIV-1

also known as MN rgp120/HIV-1 · GNE8 rgp120/HIV-1 · A244 rgp120/HIV-1 · MN rgp120/HIV-1 and GNE8 rgp120/HIV-1

Vaccine

Developed for
HIV infectious disease
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Trials 6 · a red edge is where a trial was stopped

today NCT00000879 · Ph 1 NCT00007332 · Ph 2 NCT00001096 · Ph 1 NCT00000871 · Ph 2 NCT00000866 · not/applicable
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 13 trials
Phase 1 NCT00000809 — HIV infectious disease, seronegative autoimmune hepatitis National Institute of Allergy and Infectious Diseases (NIAID) Withdrawn No outcome recorded
Phase 1 NCT00000879 ? → Apr 2005 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 1 NCT00001096 ? → Mar 2000 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 22 trials
Phase 2 NCT00000871 ? → Jan 2000 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 2 NCT00007332 ? → Apr 2003 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase not applicable1 trial
— NCT00000866 ? → Jul 1999 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as MN rsgp120/HIV-1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000809 ↗
Known as A244 rgp120/HIV-1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000871 ↗
Known as GNE8 rgp120/HIV-1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000879 ↗
1

NCT00000871 ↗
Known as MN rgp120/HIV-1 “At months 8 and 12 all groups will receive MN rgp 120/HIV-1 in alum intramuscularly.” NCT00000866 ↗
3

“high-dose MN rgp120/HIV-1 plus QS-21 plus alum” NCT00001096 ↗

NCT00000879 ↗

NCT00000871 ↗
Known as MN rgp120/HIV-1 and GNE8 rgp120/HIV-1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00007332 ↗
Modality Vaccine “HIV vaccine” NCT00000809 ↗
Route Intramuscular “MN rgp 120/HIV-1 in alum intramuscularly” NCT00000866 ↗